Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986

Maria De Santis, Joaquim Bellmunt, Graham Mead, J Martijn Kerst, Michael Leahy, Pablo Maroto, Thierry Gil, Sandrine Marreaud, Gedske Daugaard, Iwona Skoneczna, Sandra Collette, Julie Lorent, Ronald de Wit, Richard Sylvester

    612 Citationer (Scopus)

    Abstract

    This is the first randomized phase II/III trial comparing two carboplatin-based chemotherapy regimens in patients with urothelial cancer who are ineligible ("unfit") for cisplatin chemotherapy.
    OriginalsprogEngelsk
    TidsskriftJournal of Clinical Oncology
    Vol/bind30
    Udgave nummer2
    Sider (fra-til)191-9
    Antal sider9
    ISSN0732-183X
    DOI
    StatusUdgivet - 2012

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986'. Sammen danner de et unikt fingeraftryk.

    Citationsformater